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INTRODUCTION
Abnormal uterine bleeding includes all of the
menstrual abnormalities both in amount and
duration. Clinical manifestations may be a lot or a
little bleeding, elongated or irregular menstrual
cycles. This terminology is replaced by the current
menorrhagia, which is a lot menstrual bleeding or
heavy menstrual bleeding (HMB) where the
amount of bleeding of > 80 ml during the
menstrual cycle and blood only contribute as much
as 50%. While abnormal uterine bleeding caused
by coagulopathy factors, local hemostasis disorders
endometrium and ovulation disorders that were
previously included in dysfunctional uterine
bleeding (DUB).1-3
Abstract
Objective: To determine the amount of wasted blood and diag-
nosed AUB and determine amount of decrease in haemoglobin
levels by adjusting the examination of menstrual pictogram
with haemoglobin.
Methods: Diagnostic test was conducted in the Department
Obstetrics and Gynecology Dr. Mohammad Hoesin/Faculty of
Medicine Universitas Sriwijaya Palembang, start from January 2015
through January 2017. Sample was obtained from 39 patients with
abnormal uterine bleeding who meet the inclusion and exclusion
criteria. Frequency and distribution of data are described in tables
and cross analyze (cut-off point) to find cut points difference
menstrual pictogram and a decrease in haemoglobin levels using
ROC curve. Accuracy is measured by the value of Kappa. Data
analysis using SPSS version 21.
Results: From 39 samples that obtained, majority charac-
teristics age > 35 years (59%), ideal BMI (59%) and multi-
parous (48.7%). From statistical analysis, there was signifi-
cance association between haemoglobin measurement tools
and menstrual pictogram (p = 0.063). Both measuring devices
have compatibility in predicting the type of AUB (p = 0.047),
with the degree of conformity is weak (Kappa = 0.232).
Conclusion: Accuracy of menstrual pictogram examination and
haemoglobin has a weak degree of conformity, so menstrual
pictogram examination can’t be used to determine a decrease in
haemoglobin levels. Menstrual pictogram menstruation only used
as an evaluation of therapeutic response.
[Indones J Obstet Gynecol 2018; 6-3: 172-178]
Keywords: abnormal uterine bleeding, haemoglobin, menstrual pic-
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Abstrak
Tujuan: Untuk mengetahui jumlah darah yang terbuang dan dapat
menegakkan suatu diagnosis PUA dan mengetahui jumlah penurunankadar hemoglobin dengan cara menyesuaikan pemeriksaan pikto-
gram dengan pemeriksaan hemoglobin.
Metode: Uji diagnostik ini dilakukan di Departemen Obstetrik dan
Ginekologi RSUP Dr. Mohammad Hoesin/Fakultas Kedokteran Uni-
versitas Sriwijaya Palembang mulai Januari 2015 sampai Januari2017. Didapatkan sampel sebanyak 39 pasien perdarahan uterus
abnormal yang memenuhi kriteria inklusi dan eksklusi. Frekuensidan distribusi data dijelaskan dalam bentuk tabel dan dilakukan
analisis titik potong (cut off point) untuk mengetahui titik potong
selisih piktogram dan penurunan kadar hemoglobin menggunakankurva ROC. Nilai akurasi diukur dengan nilai Kappa. Analisis data
menggunakan SPSS versi 21.
Hasil: Dari 39 sampel didapatkan mayoritas memiliki karakteristik
berusia > 35 tahun (59%), IMT ideal (59%) dan multipara (48,7%).Dari analisa statistika adanya hubungan signifikan antara alat pe-
ngukuran hemoglobin dan piktogram (p = 0,063). Kedua alat ukur
memiliki kesesuaian dalam memprediksi jenis PUA (p = 0,047), denganderajat kesesuaian lemah (Kappa = 0,232).
Kesimpulan: Akurasi pemeriksaan piktogram dan pemeriksaan he-moglobin memiliki kesesuaian lemah, sehingga pemeriksaan pikto-
gram ini tidak dapat digunakan untuk mengetahui penurunan kadarhemoglobin. Piktogram menstruasi hanya dapat digunakan sebagai
evaluasi respon terapi.
[Maj Obstet Ginekol Indones 2018; 6-3: 172-178]
Kata  kunci: hemoglobin, perdarahan uterus abnormal, piktogrammenstruasi
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Based on the HIFERI consensus (2013) in Bogor,
it has been agreed that the definition of normal
menstruation is a physiological process which
occurs bleeding, mucus and cellular debris from
the uterus periodically at regular intervals that
occurred since menarche to menopause with the
exception of pregnancy and breastfeeding, which is
the result of harmonic regulation of hormonal
organs.2,4,5
Based on International Federation of Gyneco-
logy and Obstetrics (FIGO) there are nine major
categories were prepared in accordance with the
acronym "PALM-COEIN".The classification system
is based on the consideration that a patient may
have one or more factors causing abnormal uterine
bleeding. With this approach, management for AUB
patients can be more comprehensive.1,2,6-9
Management of abnormal uterine bleeding in
general, doctor needs to take account into age,
marital status, fertility, weight, type and duration
of bleeding, underlying disease and prognosis.10,11
First treatment for abnormal uterine bleeding is
stabilized the patient, cessation of bleeding using
sex steroid hormones (estrogen, progestin and
androgen), inhibitors of prostaglandin synthesis,
antifibrinolytic and operative treatment.3,4,7,10
To determine the severity of bleeding in a clini-
cal examination is often difficult. For example,
some studies have reported a lack of correlation
between the patient’s perception of the amount of
bleeding by the amount obtained from objective
calculation. When the method of estimation is sub-
jectively compared to the objective, 38-76% of
women who suffer from menorrhagia obtained
from objective estimation method. Many factors in-
fluence the patient’s perception of the amount of
bleeding, among others, menstruation duration,
age, number of used pads, amount of blood loss
and circumstances that may affect the amount of
blood loss. Higham and Shaw stated that there’s a
relationship between height, age, parity and the
amount of bleeding, but still needed an objective
measurement.12
Another method to estimate the amount of
blood loss can be done by estimating the amount
and type of pads used by a woman during
menstruation This chart is called the Pictorial
Blood Assessment Chart (PBAC) was first intro-
duced by Higham et al. in 1990 in the form of visual
inspection with a value of scoring. Total score more
than 100 points each menstrual cycle, meaning the
loss of the amount of bleeding more than 80 ml.
Validity of PBAC has been studied, debated and re-
ported that the study had a 86% sensitivity and
specificity of 89% and had been observed that 74%
of anaemia caused by menorrhagia.12-14
Janssen et al. modify PBAC techniques to create
a menstrual pictogram or scale of "bleeding" by cal-
culating the number of millilitres of blood was
found in sanitary napkins, tampons, blood clots and
spots of blood on the underwear. Menstrual picto-
gram have a higher accuracy rate than the PBAC
for every shape and size have different numbers of
absorption pads. These menstrual pictograms were
developed to create a simulation by performing
dilutions balanced between blood whole blood and
0.9% saline solution and using "Kotex" branded
pads, day and night type.12,15,16
Figure 1. Pictorial Blood Assessment Chart (PBAC)
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METHODS
This study is a diagnostic test with an observa-
tional analytic design performed on 39 women
with abnormal uterine bleeding. This research was
conducted in Department of Obstetrics and Gyne-
cology Dr. Mohammad Hoesin Hospital, Palembang
during January 2015 - January 2017. Inclusion cri-
teria were patients diagnosed with AUB, not being
pregnant, not undergoing treatment of infertility,
and willing to participate in the study and signed
informed consent.
Patients who refused to participate in the study,
history of surgical uterine (<6 weeks), complica-
tion with other diseases (kidney, liver, hyperten-
sion, cancer, diabetes mellitus, ectopic pregnancy),
hemodynamically unstable, were excluded from
the study.
All patients who met the inclusion criteria then
collected basic data including: identity, gestational
age, parity, the first day of last menstrual period
(LMP), reproductive status physical examination,
gynecology and laboratory tests. Then patient is
given a branded napkin "kotex" (day and night
type) and was given a menstrual pictogram chart
that has been taught how to fill it out and still be
evaluated by researchers. After seven days (de-
pending on the state of the patient) re-evaluation
carried out by way of summing over the use of
pads and a blood clot and conduct laboratory tests.
Data were analysed using SPSS software version
21.0; descriptive data will be analysed using Fisher
exact test, the cut off point inspection of menstrual
pictogram and haemoglobin will be displayed
through the image of the curve Receiving operating
characteristic (ROC), sensitivity, specificity, and to
assess the degree of compliance with Kappa test.
RESULTS
The demographic characteristics of the study sam-
ple are presented in Table 1. Table 1 Based note
that the majority of the sample has characteristic
aged > 35 years (59%), ideal BMI (59%), multi-
parous (48.7%).
Table 1. Demographic Characteristics (n = 39)
Characteristics n %
Aged (year)
< 25 3 7.7
25-35 13 33.3
> 35 23 59
38.2  1.107
IMT
< Underweight 4 10.3
Ideal 23 59







PUA ec PALM COEIN 39 100
Figure 2. Menstrual Pictogram
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Compliance  Pictogram  Assessment  and
Haemoglobin Assessment  in AUB Patients
Table 2 showed no significant relationship
between haemoglobin measurement tools and
pictograms (p = 0.063). However, the second
measuring instrument has its suitability in pre-
dicting the type of AUB (p = 0.047), with the
degree of conformity is weak (Kappa 0.232).
Table 2. Compliance Pictogram Assessment and Haemo-
globin
AUB Hb1.35 Hb>1.35
n % n %
Pictogram  678 3a 12.5 6b 35.29
Pictogram > 678 21c 87.5 9d 52.94
24 100 17 100
Fisher exact test, p = 0.063Kappa test = 0.232; p = 0.047
Table 2 shows as much as 65.4% (a + d) exami-
nation gives the same results (concordance). While
as much as 122.79% (b + c) give different results
(Discordant). Compliance of examination is not
65.4%, due to the conformity is bias. After correc-
tion of accidental factors, researchers obtained
pure conformity (Kappa value) of 0.23158. Because
the researchers wanted a minimum Kappa was
0.46, the examination pictogram with haemoglobin
is weak, so these tests can not be used to determine
a decrease in haemoglobin levels in AUB patients.
Analysis of Accuracy or Compliance Picto­
gram Examination with Haemoglobin
ROC analysis on Haemoglobin difference with
AUB, Haemoglobin difference is not significant in
predicting the occurrence AUB with p = 0.054.
Difference in haemoglobin cannot be used as
single predictor of AUB.
The cut off point difference in haemoglobin in
AUB patients, where a decrease in haemoglobin of
1.35 able to predict AUB events with 0.818
sensitivity and specificity of 0.5.
ROC analysis a pictogram difference in the
incidence of PUA, pictogram difference was not
significant in predicting the occurrence AUB with
p = 0.087. Pictograms difference can not be used
as a predictor of AUB. The cut off point of
difference pictograms in AUB patients, as the
reduction of 678 pictograms able to predict AUB
with specificity and sensitivity 0.394 and 0.667.
DISCUSSION
Abnormal uterine bleeding (AUB) is defined as an
increase in menstrual frequency, duration or
amount of blood loss. Abnormal uterine bleeding
may be caused partly by the growth of neoplasms,
hormone dysfunction, trauma, infection, coagu-
lopathy, and complications of pregnancy.7,17
In this study, the largest age group is > 35 years
(59%), followed by the age group 25-35 years
(33.3%), then <25 years (7.7%). The incidence of
AUB 19.1% of all visits for gynecological cases,
about 10-30% women in reproductive age and
over 50% of perimenopausal women (Haynes,
1977). Research conducted by Harlow et al. on
menstrual cycle length, reveals that the number
of population variability menstrual cycle length
immediately after menarche and just before
menopause. According to Jukic et al., age is a
major factor that led to changes in the length of
the menstrual cycle. Cycles will be shorter at the
time between early menopause and then in
the mid to late menopausal transition. Meanwhile,
according to Deligeoroglou et al., in adolescence,
prevalence is ~ 20%, the primary mechanism
involved is anovulation, due to lack of maturation
of the hypothalamic-pituitary-gonadal.18-21
In this study, incidence AUB affected most to the
ideal BMI (59%), while IMT > average (30.8%).
Results of this study is together with Beno et al.,
2010, which found that there is a relationship
between overweight and dysfunctional uterine
bleeding (DUB) (p: 0.024), but after the test
statistics, variable parity does not have a significant
effect on the occurrence of DUB (p for bivariate and
multivariate > 0.05).22-25
Most parities in this research were multiparas
19 (48.7%). Rifki et al. showed that of the 51 cases
studied, parity observed in multiparous women
with as many as 34 (66.67%). Ichimura et al.,
shows nullipara women have a high risk for the
occurrence of uterine myoma, whereas multi-
parous women have decreased relative risk for the
occurrence of uterine myoma. In multiparous with
children, more than five are at risk only 0.2% for
uterine myoma. According to Munro et al., 2011,
endometrial polyp, are common benign lesions,
asymptomatic pathogenesis, but can also contri-
bute to a regular menstrual or abnormal uterine
bleeding.7,18
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Uterine adenomyosis usually occurs in older age
compared with uterine myoma, which is between
40-50 years. The incidence is not related to parity.
More than 80% of women with uterine ade-
nomyosis have other pathological processes in the
uterus; 50% of patients with uterine myoma, an
estimated 11% with endometriosis cyst, and 7% of
cases with polyps. Bird et al. reported on the case
of uterine adenomyosis 51.2% of patients com-
plained a lot of bleeding, 10.9% irregular bleeding,
dysmenorrhea 28.3%, 2.2% and 23.9% asympto-
matic postmenopausal bleeding.7,18
The incidence of uterine myoma in women is
estimated 20-25%, up to 70-80% in studies using
the histopathological examination and ultrasono-
graphy. Ichimura et al., ovarian hormone believed
to stimulate uterine growth due to an increased
incidence after menarche and pregnancy is greater
tumour growth but decreases after menopause.
Farrer-Brown et al. showed that the most impor-
tant cause of bleeding is the presence of endo-
metrial ectasiavenules. Myoma is in the myome-
trium causing obstruction and proximal venous
congestion in the myometrial and endometrial.
Vein thrombosis and shedding were aetiology of
bleeding in the endometrium.17,26,27
Brech et al., suggests a correlation between the
severity of bleeding manifestations with a surface
area of the endometrial. Along with a surface area
of endometrial bleeding, the endometrium trigger
local hyperestrogenism conditions in the area
immediately adjacent to submucousmyoma, endo-
metrial hyperplasia and endometrial polyps will
often be found.27
Coagulopathy terminology used for systemic
hemostatic abnormalities associated with PUA.
According to Munro et al., 13% of women with
menstrual bleeding has many systemic hemostatic
disorders, and the most common is von Willebrand
disease. Ovulatory dysfunction usually occurs in
adolescent women, women with polycystic ovarian
syndrome, hyperprolactinemia, hypothyroidism,
obesity, weight loss, anorexia, excessive exercise or
in perimenopause. Usually irregular bleeding,
prolonged or shorter cycle with minimal bleeding.7
Counting the number of sanitary products is
accurate method to measure blood loss during
menstruation and also establishes the diagnosis
HMB. Barr and Janssen et al., comparing the levels
of haemoglobin women with menstrual blood loss,
measured by the alkaline hematin method as the
gold standard, obtained anaemia by 74%, while,
hematocrit, serum iron and protoporphyrin that is
inversely proportional to the amount of menstrual
blood loss. Burnet et al., (2010) inaccuracies hae-
moglobin level with alkaline hematin technique,
the accuracy rate is only 17% of the 166 research
subjects. Chudnoff et al., (2010) menstrual picto-
gram examination and haemoglobin (alkaline he-
matin) are not accurate, because the low value of
scoring bleeding on pictogram, causing false nega-
tive or false positive. In this study, 3 false negatives
(3/23; 13.0%) and 1 false positive (1/23; 7.7%) of
the 166 research subjects.28-31
This study is a clinical trial to determine the
suitability pictogram and haemoglobin examina-
tion by measuring the amount of bleeding seen
from the use of pads and given the least reference
menstrual pictogram research in Indonesia. In this
study, the gold standard could not be determined,
because the examination of pictogram and haemo-
globin has low sensitivity and specificity as well as
compliance so it can’t be used as gold standard.
There are no studies that determine the AUB by
a decrease in haemoglobin levels with pictogram,
this is the first study that tried to find the cut off
point decreasing in haemoglobin levels and a pic-
togram to uphold the AUB diagnosis. However, this
study proved that the haemoglobin or pictogram
give a weak predictive value, so we need further
research is good with more samples or other labo-
ratory assessment criteria.
From ROC assessment, we obtained haemoglo-
bin decline in predicting the AUB at 0.750% (good),
although it can’t be used because of no significance
(p = 0.054). This is due to a decrease in haemoglo-
bin is determined by the amount of bleeding in pa-
tients with AUB, while bleeding on the AUB depend
on the AUB degree itself. There are no studies that
examined the sensitivity and specificity of haemo-
globin or pictogram. The importance of this study
is as long as there is no clear limit to determine
a diagnosis and determine AUB by haemoglobin
decreased levels of haemoglobin by the pictogram.
Nevertheless, the authors recognize that there
are still many shortcomings in this study. The big
difference in the results may be caused by several
factors that can lead to bias in the form of the
number of small samples, the accuracy of which is
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used at the time of haemoglobin, the assessment
of blood on the pads and form blood clots, intra-
venous fluids, diet, blood transfusion, as well as the
body’s response to bleeding/anemia. Future re-
search may use a larger number of samples that
include AUB broad patient population to provide
valid results.
CONCLUSION
We found weak significance conformity between
pictogram inspection with haemoglobin examina-
tion. Menstrual pictogram is not a suitable method
for predicting a decrease in haemoglobin in an AUB
patient population.
RECOMMENDATION
Further research is needed regarding the accuracy
of the menstrual pictogram examination and hae-
moglobin by increasing the number of population
and sample a larger scale and bias control.
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